19F Magnetic Resonance Imaging of Perfluorocarbons for the Evaluation of Response to Antibiotic Therapy in a Staphylococcus aureus Infection Model

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Hertlein, Tobias ^a   Sturm, Volker ^a   Jakob, Peter ^a   Ohlsen, Knut ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUOROCARBON; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT; FLUORINE; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTERIUM IDENTIFICATION; BIOACCUMULATION; BIOLUMINESCENCE; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FLUORINE NUCLEAR MAGNETIC RESONANCE; IMAGE ANALYSIS; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL; DIAGNOSTIC USE; DISEASE MODEL; DRUG EFFECTS; LUMINESCENCE; MICROBIOLOGY; MUSCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; STAPHYLOCOCCAL INFECTIONS; THIGH; DRUG EFFECT;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; FLUORINE; FLUOROCARBONS; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MICE; MUSCLES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; THIGH;

EID: 84878413518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064440     Document Type: Article

References (21)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007 Oct 17 298(15): 1763-71.
2. Klein E, Smith DL, Laxminarayan R, (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007 Dec 13(12): 1840-6.
3. Mera RM, Suaya JA, Amrine-Madsen H, Hogea CS, Miller LA, et al. (2011) Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb Drug Resist. 2011 Jun;17(2): 321-8. Epub 2011 Mar 19.
4. Graveland H, Duim B, van Duijkeren E, Heederik D, Wagenaar JA (2011) Livestock-associated methicillin-resistant Staphylococcus aureus in animals and humans. Int J Med Microbiol. 2011 Dec;301(8): 630-4. Epub 2011 Oct 7.
5. Gould IM, David MZ, Esposito S, Garau J, Lina G, et al. (2012) New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents. 2012 Feb;39(2): 96-104. Epub 2011 Dec 21.
6. Wang J, Maurer L, (2005) Positron Emission Tomography: applications in drug discovery and drug development. Curr Top Med Chem. 2005 5(11): 1053-75.
7. Sandanaraj BS, Kneuer R, Beckmann N, (2010) Optical and magnetic resonance imaging as complementary modalities in drug discovery. Future Med Chem. 2010 Mar 2(3): 317-37.
8. Beckmann N, Kneuer R, Gremlich HU, Karmouty-Quintana H, et al. (2007) In vivo mouse imaging and spectroscopy in drug discovery. NMR Biomed. 2007 May 20(3): 154-85.
9. Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, et al. (2000) Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun. 2000 Jun 68(6): 3594-600.
10. Kadurugamuwa JL, Sin LV, Yu J, Francis KP, Kimura R, et al. (2003) Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob Agents Chemother. 2003 Oct 47(10): 3130-7.
11. Marzola P, Nicolato E, Di Modugno E, Cristofori P, Lanzoni A, et al. (1999) Comparison between MRI, microbiology and histology in evaluation of antibiotics in a murine model of thigh infection. MAGMA. 1999 Oct 9(1-2): 21-8.
12. Ahrens ET, Flores R, Xu H, Morel PA (2005) In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol. 2005 Aug;23(8): 983-7. Epub 2005 Jul 24.
13. Temme S, Bönner F, Schrader J, Flögel U, (2012) 19F magnetic resonance imaging of endogenous macrophages in inflammation. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 May-Jun 4(3): 329-43 doi: 10.1002/wnan.1163. Epub 2012 Feb 21.
14. Ebner B, Behm P, Jacoby C, Burghoff S, French BA, et al. (2010) Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc Imaging. 2010 Mar;3(2): 202-10. Epub 2010 Jan 8.
15. Stoll G, Basse-Lüsebrink T, Weise G, Jakob P (2012) Visualization of inflammation using (19) F-magnetic resonance imaging and perfluorocarbons. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 Jul;4(4): 438-47. Epub 2012 Mar 15. doi:10.1002/wnan.1168.
16. Hertlein T, Sturm V, Kircher S, Basse-Lüsebrink T, Haddad D, et al. (2011) Visualization of abscess formation in a murine thigh infection model of Staphylococcus aureus by 19F-magnetic resonance imaging (MRI). PLoS One. 2011 Mar 24 6(3): e18246.
17. Flögel U, Ding Z, Hardung H, Jander S, Reichmann G, et al. (2008) In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation. 2008 Jul 8;118(2): 140-8. Epub 2008 Jun 23.
18. LaPlante KL, Leonard SN, Andes DR, Craig WA, Rybak MJ (2008) Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrob Agents Chemother. 2008 Jun;52(6): 2156-62. Epub 2008 Apr 14.
19. Craig WA, Redington J, Ebert SC, (1991) Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. J Antimicrob Chemother. 27Suppl C: 29-40.
20. Pohmann R, von Kienlin M, (2001) Accurate Phosphorus Metabolite Images of the Human Heart by 3D Acquisition-Weighted CSI. Magn Reson Med 45(5): 817-26.
21. Speck O, Scheffler K, Hennig J, (2002) Fast 31P Chemical Shift Imaging Using SSFP Methods. Magn Reson Med 48(4): 633-9.